Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000108

Director acquired 6,470 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Dubin Glenn Director 2023-10-02 Grant or award +6,470 $1.70 $10,999 19,030 D
Loading xslF345X05/wk-form4_1696364836.xml…